Roivant Sciences (Nasdaq: ROIV) is a holding company that builds focused subsidiary biotech and health-tech operating units called "Vants." Founded by Vivek Ramaswamy in 2014 and now led by CEO Matt Gline, Roivant has launched companies across immunology (Immunovant, Priovant, Covant, PsiThera), pulmonology (Pulmovant), delivery technology… - View it on GitHub